Collateral sensitivity as a strategy against cancer multidrug resistance
KM Pluchino, MD Hall, AS Goldsborough… - Drug Resistance …, 2012 - Elsevier
While chemotherapy remains the most effective treatment for disseminated tumors, acquired
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
[引用][C] Collateral sensitivity as a strategy against cancer multidrug resistance
KM Pluchino, MD Hall, AS Goldsborough… - Drug Resistance …, 2012 - cir.nii.ac.jp
Collateral sensitivity as a strategy against cancer multidrug resistance | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Collateral sensitivity as a strategy against cancer multidrug resistance.
KM Pluchino, MD Hall, AS Goldsborough… - … and Commentaries in …, 2012 - europepmc.org
While chemotherapy remains the most effective treatment for disseminated tumors, acquired
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
[HTML][HTML] Collateral sensitivity as a strategy against cancer multidrug resistance
KM Pluchino, MD Hall, AS Goldsborough… - Drug Resistance …, 2012 - ncbi.nlm.nih.gov
While chemotherapy remains the most effective treatment for disseminated tumors, acquired
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
Collateral sensitivity as a strategy against cancer multidrug resistance
KM Pluchino, MD Hall… - Drug resistance …, 2012 - pubmed.ncbi.nlm.nih.gov
While chemotherapy remains the most effective treatment for disseminated tumors, acquired
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
Collateral sensitivity as a strategy against cancer multidrug resistance
KM Pluchino, MD Hall, AS Goldsborough… - Drug Resistance …, 2012 - infona.pl
While chemotherapy remains the most effective treatment for disseminated tumors, acquired
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
Collateral sensitivity as a strategy against cancer multidrug resistance.
KM Pluchino, MD Hall, AS Goldsborough… - … and Commentaries in …, 2012 - europepmc.org
While chemotherapy remains the most effective treatment for disseminated tumors, acquired
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
Collateral sensitivity as a strategy against cancer multidrug resistance
KM Pluchino, MD Hall, AS Goldsborough… - Drug Resistance …, 2012 - infona.pl
While chemotherapy remains the most effective treatment for disseminated tumors, acquired
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …